Form 8-K - Current report:
SEC Accession No. 0001104659-24-082155
Filing Date
2024-07-24
Accepted
2024-07-24 09:01:23
Documents
21
Period of Report
2024-07-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416389d3_8k.htm   iXBRL 8-K 34482
2 EXHIBIT 4.1 tm2416389d3_ex4-1.htm EX-4.1 127988
3 EXHIBIT 5.1 tm2416389d3_ex5-1.htm EX-5.1 8622
4 EXHIBIT 10.1 tm2416389d3_ex10-1.htm EX-10.1 274001
5 EXHIBIT 99.1 tm2416389d3_ex99-1.htm EX-99.1 9981
6 EXHIBIT 99.2 tm2416389d3_ex99-2.htm EX-99.2 9867
10 GRAPHIC tm2416389d3_ex5-1img001.jpg GRAPHIC 2525
11 GRAPHIC tm2416389d3_ex99-1img001.jpg GRAPHIC 4420
12 GRAPHIC tm2416389d3_ex99-2img001.jpg GRAPHIC 4452
  Complete submission text file 0001104659-24-082155.txt   770062

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20240722.xsd EX-101.SCH 3054
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20240722_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20240722_pre.xml EX-101.PRE 22385
23 EXTRACTED XBRL INSTANCE DOCUMENT tm2416389d3_8k_htm.xml XML 3795
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40363 | Film No.: 241136338
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)